The global Procalcitonin market is comprehensively analyzed in the report with the main objective of providing accurate market data and useful recommendations to help players to gain strong growth in the future. The report is compiled by subject matter experts and experienced market analysts, which makes it highly authentic and reliable. Readers are provided with a deep analysis of historical and future market scenarios to get a sound understanding of market competition and other important aspects. The report offers exhaustive research on market dynamics, key segments, leading players, and different regional markets. It is a complete package of thorough analysis and research on the Procalcitonin market.
The global Procalcitonin (CAS 56645-65-9) market was 62 million US$ in 2018 and is expected to 93 million US$ by the end of 2025, growing at a CAGR of 5.2% between 2019 and 2025.
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin, and katacalcin. It can be expressed in E. coli
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with a severe bacterial infection. PCT is, therefore, an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
Expressed in E.coli, PCT can be used as a reagent to prepare calibrators for procalcitonin or calcitonin immunoassays.
The global procalcitonin market had reached 126.4 g in 2016 and is expected to increase reach 212.6 g by 2023. In terms of revenue, the global procalcitonin chloride market was valued 61.85 Million USD in 2016 and is estimated to be worth 92.27 Million USD by 2023. Overall, the procalcitonin products performance is positive with the global economic recovery.
The manufacture region is concentrated in the USA, Europe, China, and Japan, of which Europe is the largest region with a share of 36.92% in 2016. The production shares of Europe, China, and Japan were 23.07%, 19.12%, and 6.43%.
The consumption share of North America, Europe, Asia Pacific were 26.73%, 28.27%, 35.77% in 2016. The Asia Pacific is the main export region.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in the Procalcitonin market will become more intense.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1086635/global-procalcitonin-cas-56645-65-9-market
The competitive landscape of the global Procalcitonin market is broadly studied in the report with large focus on recent developments, future plans of top players, and key growth strategies adopted by them. The analysts authoring the report have profiled almost every major player of the global Procalcitonin market and thrown light on their crucial business aspects such as production, areas of operation, and product portfolio. All companies analyzed in the report are studied on the basis of vital factors such as market share, market growth, company size, production volume, revenue, and earnings.
Procalcitonin Market Leading Players
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Nanjing Norman Biological Technology
Shanghai Medicine’nest Pharmaceutical
The report answers important questions that companies may have when operating in the global Procalcitonin market. Some of the questions are given below:
• What will be the size of the global Procalcitonin market in 2025?
• What is the current CAGR of the global Procalcitonin market?
• Which product is expected to show the highest market growth?
• Which application is projected to gain a lion’s share of the global Procalcitonin market?
• Which region is foretold to create the most number of opportunities in the global Procalcitonin market?
• Will there be any changes in market competition during the forecast period?
• Which are the top players currently operating in the global Procalcitonin market?
• How will the market situation change in the coming years?
• What are the common business tactics adopted by players?
• What is the growth outlook of the global Procalcitonin market?
Answering such types of questions can be very helpful for players to clear their doubts when implementing their strategies to gain growth in the global Procalcitonin market. The report offers a transparent picture of the real situation of the global Procalcitonin market so that companies can operate more effectively. It can be customized according to the needs of readers for a better understanding of the global Procalcitonin market.
Request Customization of Report at https://www.qyresearch.com/customize-request/form/1086635/global-procalcitonin-cas-56645-65-9-market
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.”